Innovation Spotlight: Akili: Gaming

Report Code: IFT204A


July 2020

Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent pediatric neurodevelopmental conditions, affecting between 3% and 7% of school-aged children (Felt et al., 2014). It is commonly treated using some combination of counseling, behavioral changes and pharmacological agents including stimulants. Various childfriendly intermediate- and long-acting formulations of methylphenidate and dexmethylphenidate are available; however, their use remains controversial (Krizinger et al., 2019).

Continue reading this report plus more!

Monthly Access $9.99

  • Access to our Library of published and upcoming Innovation Spotlights
  • Access to thousands of select free reports from publishers such as Barnes Reports, TBRC, Verified Market Research, & Primary Research Group
  • Exclusive discounts on full length reports from BCC Research & various additional publishers
  • Cancel at anytime

Single Paper $59.99

  • One Time Purchase
  • Downloadable PDF